A plain-language guide for Texas healthcare business owners considering a sale. Valuation, payor mix, licensing, and what serious buyers look for in healthcare acquisitions.
Selling a healthcare business is like selling a ship while it is still at sea. The hull has to be sound. The crew has to agree to stay. The navigation license has to transfer. And if any one of those three things is not in order, you are not going anywhere. Not at the price you want. Not on the timeline you planned. Not with the buyer who made you the best offer.
I have been in the room on enough of these transactions to tell you that the complexity is not the business. Healthcare businesses can be excellent. The complexity is the deal. Licensing, payor contracts, corporate practice of medicine restrictions, reimbursement exposure, and compliance history all affect how a healthcare transaction gets structured and how long it takes to close. A general business broker will cost you money here. This is written from the perspective of a buyer who has done this work in Texas, and who knows exactly what kills these deals.
Home health agencies, outpatient therapy practices (PT, OT, speech), behavioral health, urgent care, dental practices, medical billing companies, and healthcare staffing businesses are all active acquisition targets in the lower middle market right now. Each sub-sector has its own regulatory profile and valuation logic. They are not interchangeable.
Ambulatory surgery centers and physician practices carry additional regulatory complexity, particularly around corporate practice of medicine rules and passive ownership structures. Berkman Woods focuses on services-based healthcare businesses with $500K–$5M in EBITDA. If you are in that range and running a clean operation, you have buyers. The question is whether your business is ready to withstand what those buyers are going to find when they look.
Payor mix is the first conversation in every healthcare diligence process, every time. Medicare and Medicaid revenue is real, but it comes with audit risk, reimbursement rate exposure, and regulatory scrutiny that private-pay and commercial insurance revenue does not. Buyers underwrite payor mix carefully. Commercial-heavy books trade at a premium over government-heavy ones. That spread is significant and it is not negotiable.
Census stability and admission trends matter more than any single revenue snapshot. A business that shows consistent patient or client volume over 24–36 months is worth more than one with a volatile recent quarter. Buyers are underwriting the future cash flow. The trailing twelve months is just where they start the conversation.
Clinical compliance history gets reviewed exhaustively. Survey results, state deficiencies, and any OIG exclusions are all part of diligence. One hidden compliance issue will kill a healthcare deal or reprice it by 20–30%. I have seen both happen. Buyers who find problems in diligence do not overlook them as a courtesy. They adjust the price or walk. And that decision happens on their timeline, not yours.
Healthcare services businesses trade at 4x–8x EBITDA, a wider range than most sectors in the lower middle market. That spread exists because payor mix, regulatory risk, and growth trajectory vary enormously within the same sub-sector. A home health agency with 60% Medicare revenue and a clean survey history looks very different from one with three state deficiencies in the last 24 months. Both are home health agencies. Their multiples are not close to each other.
EBITDA is normalized for physician compensation, which is often above or below market depending on the ownership structure, and for non-recurring costs. Both buyers and lenders will do their own EBITDA normalization. The numbers need to hold up to both analyses. Not just yours.
Healthcare business sales frequently require change of ownership applications, re-enrollment with payors, and in some states, Certificate of Need determinations. Texas has limited CON requirements compared to other states, which makes this market more open to acquisitions. That is a meaningful advantage for Texas sellers.
But Medicare provider agreements and Medicaid enrollment still transfer on their own timelines, completely independent of your closing date. A buyer who does not understand this will blow your planned close date by 60–90 days. Plan for payor re-enrollment timelines when you structure your deal. Not after the LOI is signed. After the LOI, you are working inside the constraints the deal already created.
SBA 7(a) financing is available for many healthcare businesses but has restrictions that apply to physician practices with passive ownership structures and businesses with certain licensing arrangements. Home health, outpatient therapy, behavioral health, and healthcare services companies without corporate practice of medicine complications typically qualify for SBA acquisition financing without issue.
For deals that do not qualify, private credit and mezzanine structures are used. These approaches require higher EBITDA floors, typically $1.5M or above, and more buyer equity, but they allow for more flexible deal structures where SBA rules create constraints. Knowing which path applies to your business before you start talking to buyers saves everyone a significant amount of time.
I have seen two versions of this scenario. In the first, an owner discovered a compliance issue three weeks before close. The buyer found it in the data room, buried inside 400 pages of survey documentation. What followed was not a pleasant negotiation. The deal repriced significantly, the timeline blew up, and the seller spent the next six weeks feeling like the walls were closing in. I have seen that buyer's face when they found it. It did not look like a man who was going to give anyone the benefit of the doubt.
In the second version, the seller surfaced the same type of issue during preparation, months before going to market. They documented it. They showed the resolution plan. They brought it up in the first substantive conversation with the buyer. That seller controlled the narrative. The discount was real but it was reasonable. The deal closed.
Same type of problem. Completely different outcome. The difference was who found it first, and what position that put everyone in.
Berkman Woods acquires healthcare businesses in Texas and Oklahoma. If you are considering a sale in the next 12–24 months, reach out for a direct conversation about what your business is worth and what the process actually looks like for your specific situation.
Related: Healthcare · For Business Owners
